Canadian company Kardium has raised C$340m ($250m) to support the launch of its Globe pulsed field (PF) system for treating atrial fibrillation (AFib).
The latest fund raise brings the company’s total capital to $425m and...
Canadian company Kardium has raised C$340m ($250m) to support the launch of its Globe pulsed field (PF) system for treating atrial fibrillation (AFib).
The latest...
CroíValve announced it received new funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Program.
EIC awarded the funding as part of the EU’s Horizon...
Field Medical announced today that it closed a Series B funding round worth proceeds totaling $35 million.
BioStar Capital and Cue Growth led the round,...
Escala Medical has been awarded €4.5m ($5.3m) to drive market expansion of its Mendit device for women with pelvic organ prolapse (POP).
Around €2.5m ($2.9m)...
InterShunt Technologies announced it began an early feasibility study of its device for reducing heart failure symptoms.
Dr. Sitaramesh Emani and the Structural Heart Intervention...
Foldax announced one-year results from a clinical trial of its Tria polymer mitral heart valve offering.
In a trial based in India, the mitral valve...
STENTiT, a pioneering medical device company, developing a novel class of stents with regenerative properties, today announced the successful implantation of its Resorbable Fibrillated...
Endovascular Engineering (E2) has completed enrolment of subjects in the pivotal cohort of its ENGULF trial, involving the Hēlo PE Thrombectomy System.
The investigational device...
Canadian company Kardium has raised C$340m ($250m) to support the launch of its Globe pulsed field (PF) system for treating atrial fibrillation (AFib).
The latest...
CroíValve announced it received new funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Program.
EIC awarded the funding as part of the EU’s Horizon...
Field Medical announced today that it closed a Series B funding round worth proceeds totaling $35 million.
BioStar Capital and Cue Growth led the round,...
Escala Medical has been awarded €4.5m ($5.3m) to drive market expansion of its Mendit device for women with pelvic organ prolapse (POP).
Around €2.5m ($2.9m)...